"Full service obstetrics and gynecology services"

During the past decade, Rosemark Women Care Specialists conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 12 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rosemark Women Care Specialists" #1 sponsor was "Coloplast A/S" with 4 trials, followed by "Curatek Pharmaceuticals, LLC" with 3 trials sponsored, "Lumara Health, Inc." with 3 trials sponsored, "AMAG Pharmaceuticals, Inc." with 2 trials sponsored and "ASTORA Women's Health" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rosemark Women Care Specialists" #1 collaborator was "Chemo France" with 1 trials as a collaborator, "Daré Bioscience, Inc." with 1 trials as a collaborator, "Health Decisions" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Registrat-Mapi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Rosemark Women Care Specialists" are "Contraception" (4 trials), "Vaginal Infection" (3 trials), "Irritable Bowel Syndrome" (2 trials), "Pelvic Organ Prolapse" (2 trials) and "Stress Urinary Incontinence" (2 trials). Many other conditions were trialed in "Rosemark Women Care Specialists" in a lesser frequency.

Most popular intervention types in "Rosemark Women Care Specialists" are "Drug" (24 trials), "Device" (6 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Metronidazole" (2 trials), "Terconazole" (2 trials), "placebo" (2 trials) and "AMS Apogee™ with IntePro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rosemark Women Care Specialists" are 25 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Rosemark Women Care Specialists". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Rosemark Women Care Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rosemark Women Care Specialists, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".